Q BioMed announces publication of research showing augmented efficacy of its drug candidate Uttroside-B against liver cancer
MarketScreener,
NEW YORK, March 16, 2022 /PRNewswire/ -- Q BioMed, Inc. (OTCQB: QBIO) a commercial-stage biotechnology development company…